At Fogarty, we often hear of our graduates publishing in influential journals. Today we are proud to announce that Surbhi Sarna, founder and former CEO of nVision, a Fogarty graduate, is releasing a book this spring. “Without a Doubt: How to Go from Underrated to...
Medtech success stories are always inspiring and there is nothing better than hearing one from a Fogarty alumni company. Joe Eibl, CEO of Flosonics, visited FI earlier this month to give a Lunch & Learn educational talk describing his company’s journey from...
Fogarty graduate EchoPixel helped revolutionize heart surgery with its True3D, a turnkey surgical planning software that creates a hologram of the heart for study before an incision is ever made. With FDA 510(k) clearance, True3D has already been implemented by more...
PQ Bypass, one of the first Fogarty Innovation startups, was recently acquired by Endologix LLC, a leader in the treatment of vascular disease. The addition of the PQ Bypass technology portfolio, which targets the treatment of complex superficial femoral artery (SFA)...
Thanks to its recent acquisition by Merck on behalf of its planned spinoff of Organon, Alydia Health, a Fogarty Innovation graduate, is one step closer to its goal of eradicating postpartum hemorrhage (PPH), the leading global cause of maternal death. The deal is...
Securing financial backing is always a hot topic for startups, and never more so than today, when COVID-19 has upset the traditional landscape. That was the topic of “Medtech Innovation: The Post-COVID World of Innovation,” at the recent Transcatheter...
It’s always encouraging to hear about medtech entrepreneurs finding success. But have you ever wondered how they got there? The road, as you’d assume, is not straight, as nearly 100 FDA participants heard from successful entrepreneurs at an engaging, educational panel...
COVID-19 might have temporarily closed dentist offices, but that hasn’t stopped iDentical from raising a healthy amount of cash for its innovative alternative to traditional dental implants. Fogarty Institute company-in-residence iDentical has developed drill-free,...
Most successful professionals will agree that if there is a “secret to success,” it’s having a mentor. And that holds true for the medtech profession as well, judging by the results of our Diversity by Doing (DxD) HealthTech survey. As noted in our recent report, both...
It has been an action-packed 12 months for EnSpectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology. While 2019 brought a number of notable developments, most recently EnSpectra received a $2 million grant that...